NBT Bancorp Inc.
NBT Bancorp Inc. (NASDAQ: NBTB) relating to its proposed merger with Salisbury Bancorp, Inc. Under the terms of the merger, Salisbury shareholders will receive 0.745 shares of NBT per share they own.
NBT Bancorp Inc. (NASDAQ: NBTB) relating to its proposed merger with Salisbury Bancorp, Inc. Under the terms of the merger, Salisbury shareholders will receive 0.745 shares of NBT per share they own.
Energy Vault Holdings, Inc. (NYSE: NRGV) relating to the transaction between Energy Vault, Inc. and the SPAC called Novus Capital Corporation II (“NXU”) for potential violations of securities laws and breaches of fiduciary duties by directors of NXU.
First Miami Bancorp, Inc. (OTC: FMIA), relating to its proposed sale to United Community Banks, Inc. Under the terms of the agreement, FMIA shareholders are expected to receive 10.2685 shares of United per share they own.
NuVasive, Inc. (NASDAQ: NUVA), relating to its proposed sale to Globus Medical, Inc. Under the terms of the agreement, NUVA shareholders are expected to receive 0.75 shares of Globus per share they own.
Cardiovascular Systems, Inc. (NASDAQ: CSII), relating to its proposed sale to Abbott Laboratories. Under the terms of the agreement, CSII shareholders are expected to receive $20.00 in cash per common share they own.
Sumo Logic, Inc. (NASDAQ: SUMO), relating to its proposed sale to affiliates of Francisco Partners. Under the terms of the agreement, SUMO shareholders are expected to receive $12.05 in cash per share they own.
Oak Street Health, Inc. (NYSE: OSH), relating to its proposed sale to CVS Health. Under the terms of the agreement, OSH shareholders are expected to receive $39.00 in cash per share they own.
Argo Group International Holdings, Ltd. (NYSE: ARGO), relating to its proposed sale to Brookfield Reinsurance. Under the terms of the agreement, ARGO shareholders are expected to receive $30.00 in cash per share they own
AlerisLife Inc. (NASDAQ: ALR), relating to its proposed sale to APB Acquisition LLC. Under the terms of the agreement, ALR shareholders are expected to receive $1.31 in cash per share they own.
Chembio Diagnostics, Inc. (NASDAQ: CEMI), relating to its proposed sale to Biosynex SA. Under the terms of the agreement, CEMI shareholders are expected to receive $0.45 in cash per share they own.